Clinical Trials Logo

Clinical Trial Summary

Individuals with suspected primary immunodeficiency will be studied and the results compared with healthy controls. Primary immunodeficiency may manifest as recurrent, severe or unusual infections as well as signs and symptoms of immune dysregulation such as autoimmunity or lymphoproliferation.


Clinical Trial Description

Patients with a suspected immunodeficiency will be identified and invited to participate. Upon agreement, an additional blood sample will be collected when they have their routine bloods taken. If the study participants undergoes anaesthesia for any other reason, a small skin biopsy will be taken as well. Additional samples including blood samples or mouth swabs will be taken from healthy family members. Blood from healthy controls will only be taken when there is a clinical need for blood sampling (or when the study participant is already anaesthetised for any other reason) and not for research purposes only. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02735824
Study type Observational
Source University Children's Hospital, Zurich
Contact Jana M Pachlopnik Schmid, MD PhD
Phone +41 44 266 73 11
Email jana.pachlopnik@kispi.uzh.ch
Status Recruiting
Phase
Start date February 2016
Completion date December 2027

See also
  Status Clinical Trial Phase
Completed NCT04798677 - Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine N/A
Completed NCT02783482 - Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency Phase 3
Completed NCT00598481 - ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID Phase 2
Completed NCT00468273 - A Clinical Study of Intravenous Immunoglobulin Phase 3
Completed NCT01727895 - Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans N/A
Enrolling by invitation NCT03478670 - Strimvelis Registry Study to Follow-up Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID)
Terminated NCT00006054 - Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies N/A
Recruiting NCT03920735 - Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients
Completed NCT00001438 - A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes Phase 2
Terminated NCT00811174 - Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases Phase 3
Completed NCT00006131 - Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster N/A
Completed NCT02554630 - Novel Mechanisms and Approaches to Treat Neonatal Sepsis
Recruiting NCT03835312 - Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM N/A
Completed NCT00176865 - Stem Cell Transplant for Immunologic or Histiocytic Disorders Phase 2
Completed NCT00001646 - Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis Phase 3
Completed NCT02630082 - Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru N/A
Completed NCT00001158 - Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System N/A